Literature DB >> 23195331

αC helix displacement as a general approach for allosteric modulation of protein kinases.

Lorenzo Palmieri1, Giulio Rastelli.   

Abstract

Owing to their crucial role in the modulation of cell pathways, protein kinases are important targets for several human diseases, including but not limited to cancer. The classic approach of targeting the ATP active site has recently come up against selectivity issues, which can be considerably reduced by following an allosteric modulation approach. Being closely related to protein kinase inactivation, allosteric targeting via displacement of the conserved structural αC helix enables a direct and specific modulation mechanism. A structure-based survey of the allosteric regulation of αC helix conformation in various kinase families is provided, highlighting key allosteric pockets and modulation mechanisms that appear to be more broadly conserved than was previously thought.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23195331     DOI: 10.1016/j.drudis.2012.11.009

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  36 in total

1.  Slow inhibition and conformation selective properties of extracellular signal-regulated kinase 1 and 2 inhibitors.

Authors:  Johannes Rudolph; Yao Xiao; Arthur Pardi; Natalie G Ahn
Journal:  Biochemistry       Date:  2014-12-04       Impact factor: 3.162

Review 2.  Drugs for allosteric sites on receptors.

Authors:  Cody J Wenthur; Patrick R Gentry; Thomas P Mathews; Craig W Lindsley
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013-10-02       Impact factor: 13.820

3.  Atomistic insights into the lung cancer-associated L755P mutation in HER2 resistance to lapatinib: a molecular dynamics study.

Authors:  Bei Yang; Haiping Zhang; Hao Wang
Journal:  J Mol Model       Date:  2015-01-27       Impact factor: 1.810

4.  Identification of RIPK3 Type II Inhibitors Using High-Throughput Mechanistic Studies in Hit Triage.

Authors:  Amy C Hart; Lynn Abell; Junqing Guo; Michael E Mertzman; Ramesh Padmanabha; John E Macor; Charu Chaudhry; Hao Lu; Kevin O'Malley; Patrick J Shaw; Carolyn Weigelt; Matthew Pokross; Kevin Kish; Kyoung S Kim; Lyndon Cornelius; Andrew E Douglas; Deepa Calambur; Ping Zhang; Brian Carpenter; William J Pitts
Journal:  ACS Med Chem Lett       Date:  2019-05-06       Impact factor: 4.345

5.  Binding site multiplicity with fatty acid ligands: implications for the regulation of PKR kinase autophosphorylation with palmitate.

Authors:  Liang Fang; Hyun Ju Cho; Christina Chan; Michael Feig
Journal:  Proteins       Date:  2014-06-03

6.  Targeting Dynamic ATP-Binding Site Features Allows Discrimination between Highly Homologous Protein Kinases.

Authors:  Sujata Chakraborty; Takayuki Inukai; Linglan Fang; Martin Golkowski; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

7.  Characterization and prevalence of two novel CHEK2 large deletions in Greek breast cancer patients.

Authors:  Paraskevi Apostolou; Florentia Fostira; Vasiliki Mollaki; Angeliki Delimitsou; Metaxia Vlassi; George Pentheroudakis; Eleni Faliakou; Panagoula Kollia; George Fountzilas; Drakoulis Yannoukakos; Irene Konstantopoulou
Journal:  J Hum Genet       Date:  2018-05-22       Impact factor: 3.172

8.  Molecular dynamics simulations reveal the conformational dynamics of Arabidopsis thaliana BRI1 and BAK1 receptor-like kinases.

Authors:  Alexander S Moffett; Kyle W Bender; Steven C Huber; Diwakar Shukla
Journal:  J Biol Chem       Date:  2017-05-30       Impact factor: 5.157

9.  Allosteric Control of a Plant Receptor Kinase through S-Glutathionylation.

Authors:  Alexander S Moffett; Kyle W Bender; Steven C Huber; Diwakar Shukla
Journal:  Biophys J       Date:  2017-12-05       Impact factor: 4.033

10.  Structure-based discovery of the first allosteric inhibitors of cyclin-dependent kinase 2.

Authors:  Giulio Rastelli; Andrew Anighoro; Martina Chripkova; Laura Carrassa; Massimo Broggini
Journal:  Cell Cycle       Date:  2014-06-09       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.